Cloud Banner

Pharmaceutical

Image

Global Danon Disease Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Aug 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Danon Disease Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 6.5% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1647.18 Million
Diagram Market Size (Forecast Year) USD 2820.00 Million
Diagram CAGR 6.5%

Global Danon Disease Treatment Market, By Treatment (Medication, Cardiac ablation therapy, Physical therapy, Genetic counseling, Gene therapy, and Others), Diagnosis (Biopsy, Genetic testing, New born screening, and Others), Symptoms (Cardiomyopathy, Myopathy, Intellectual Disability, Stomach Problems, Difficulty Breathing, Visual Abnormalities, and Others), End-Users (Clinic, Hospital, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Industry Trends and Forecast to 2030.

Danon Disease Treatment Market

Danon Disease Treatment Market Analysis and Size

The rise in the prevalence of disease, growing government initiatives, advancement in treatment options, genetic counseling, and rising awareness are the factors that will expand the global danon disease treatment market. Increasing R&D activities and the growing focus of major pharmaceutical companies toward novel treatment therapies will provide beneficial opportunities for the global danon disease treatment market in the forecast period of 2023-2030.

There is no cure for danon disease as the treatment aims to improve symptoms, and high cost of treatment is the factor that will hamper the market growth and further challenge the market growth.                  

Data Bridge Market Research analyses that the danon disease treatment market, which was USD  1,647.18  million in 2023, would rocket up to USD 2,820.00 million by 2030 and is expected to undergo a CAGR of 6.50% during the forecast period. This indicates the market value. "Medication" dominates the treatment segment of the danon disease treatment market due to increasing awareness about the danon disease treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Danon Disease Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Treatment (Medication, Cardiac ablation therapy, Physical therapy, Genetic counseling, Gene therapy and Others), Diagnosis (Biopsy, Genetic testing, New born screening, and Others), Symptoms (Cardiomyopathy, Myopathy, Intellectual Disability, Stomach Problems, Difficulty Breathing, Visual Abnormalities, and Others), End-Users (Clinic, Hospital, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa

Market Players Covered

Rocket Pharmaceuticals, Ltd. (U.S.), Sanofi (France), GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), AstraZeneca (U.K.), and Array BioPharma (U.S.) among others.

Market Opportunities

  • Rising demand for minimally invasive treatments
  • Development of new formulations and delivery methods
  • Rising personalized medicine approaches

Market Definition

Danon disease is a rare inherited metabolic disorder characterized by weakening of the heart muscle (cardiomyopathy), weakening of the muscles used for movement (skeletal muscle myopathy), and intellectual disability. It is caused due to mutations in the LAMP2 gene. This condition is a type of lysosomal storage disorder. Danon disease is also known as Glycogen Storage Disease Type 2B, Lysosomal Glycogen Storage Disease with Normal Acid Maltase. Cardiomyopathy is the most common symptom of this disorder.

The market for danon disease treatment includes the production, distribution, and sales of the medication worldwide. It involves pharmaceutical companies that manufacture danon disease treatment, healthcare facilities where it is administered, and various stakeholders such as physicians, patients, and regulatory authorities involved in its prescription, usage, and approval.            

Danon Disease Treatment Market Dynamics

Drivers

  • Increasing Prevalence of Danon Disease

The increasing prevalence of Danon disease is a significant driver for the global Danon disease treatment market. Danon disease is a rare genetic disorder characterized by the dysfunction of lysosomes, which are responsible for breaking down waste materials within cells. This condition primarily affects the heart, skeletal muscles, and cognitive functions.

  • Improving Healthcare Infrastructure

Improving healthcare infrastructure significantly drives the global Danon disease treatment market. Danon disease, a rare genetic disorder, requires specialized medical care and access to advanced diagnostic tools, treatment facilities, and technical healthcare professionals. The availability of a robust healthcare infrastructure is vital in ensuring timely and effective diagnosis, treatment, and management of danon disease.

  • Increase in Research and Development Activities

Growing R&D activities serve as a significant driver for the market. Danon disease, a rare genetic disorder, poses unique challenges in understanding its underlying mechanisms and developing effective treatment options. However, the increasing focus on rare diseases and the urgency to address unmet medical needs have led to a surge in R&D efforts dedicated to danon disease.  

Opportunities

  • Advancements in Medical Technology

Technological advancements in diagnostic techniques, imaging modalities, and telemedicine have improved the identification and management of danon disease. These advancements enhance the effectiveness and efficiency of danon disease treatment, further creating the opportunity for market growth.

Restraints/Challenges

  • Limited awareness and understanding

Despite the increasing prevalence of Danon disease, healthcare professionals lack awareness and understanding, which can lead to delayed or misdiagnosis. This limited awareness can hinder timely access to appropriate treatments and delay the development of new therapeutic approaches.

This global danon disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Danon disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In September 2022, Rocket Pharmaceuticals, Inc. announced positive clinical updates from its Phase 1 Danon Disease Trial for RP-A501 through an oral poster session at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022.

Global Danon Disease Treatment Market Scope

The market is segmented on the basis of treatment, diagnosis, symptoms, end users, and distribution channel. The growth amongst these segments will help you meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Medication
  • Cardiac ablation therapy
  • Physical therapy
  • Genetic counseling
  • Gene therapy
  • Others

Diagnosis

  • Biopsy
  • Genetic testing
  • New born screening
  • Others

Symptoms

  • Cardiomyopathy
  • Myopathy
  • Intellectual Disability
  • Stomach Problems
  • Difficulty Breathing
  • Visual Abnormalities
  • Others

End User

  • Clinic
  • Hospital
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Danon Disease Treatment Market Regional Analysis/Insights

The market is analysed, and market size insights and trends are provided by country, treatment, diagnosis, symptoms, end users, and distribution channel as referenced above.

The countries covered in the danon disease treatment market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa.

 North America is dominating the market due to the increasing prevalence of the danon disease in that region. The Asia Pacific is the fastest-growing region due to the rising geriatric population in the region.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The danon disease treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for danon disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the danon disease treatment market. The data is available for historic period 2010-2020.

Competitive Landscape and Danon disease treatment Market Share Analysis

The Danon disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to danon disease treatment market.

Some of the major players operating in the  danon disease treatment market are:

  • Rocket Pharmaceuticals, Ltd. (U.S.)
  • Sanofi (France)
  • GlaxoSmithKline plc (U.K.)
  • Pfizer Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • AstraZeneca (U.K.)
  • Array BioPharma (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Danon Disease Treatment Market will be worth USD 2,820.00 million by 2030.
The Danon Disease Treatment Market Growth Rate is 6.50% during the forecast period.
The Increasing Prevalence of Danon Disease, Improving Healthcare Infrastructure and Increase in Research and Development Activities are the Growth drivers of the Danon Disease Treatment Market.
The treatment, diagnosis, symptoms, end users, and distribution channel are the factors on which the Danon Disease Treatment Market research is based.
The Rocket Pharmaceuticals, Inc. announced positive clinical updates from its Phase 1 Danon Disease Trial for RP-A501 through an oral poster session at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022 are the latest developments in the Danon Disease Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials